divalproex sodium

Generic: divalproex sodium

Labeler: bryant ranch prepack
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name divalproex sodium
Generic Name divalproex sodium
Labeler bryant ranch prepack
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

divalproex sodium 500 mg/1

Manufacturer
Bryant Ranch Prepack

Identifiers & Regulatory

Product NDC 71335-1883
Product ID 71335-1883_6dcd8d8d-3860-46c8-a8dd-3003604bc821
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA209286
Listing Expiration 2026-12-31
Marketing Start 2020-09-18

Pharmacologic Class

Classes
anti-epileptic agent [epc] decreased central nervous system disorganized electrical activity [pe] mood stabilizer [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 713351883
Hyphenated Format 71335-1883

Supplemental Identifiers

RxCUI
1099569
UNII
644VL95AO6

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name divalproex sodium (source: ndc)
Generic Name divalproex sodium (source: ndc)
Application Number ANDA209286 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 500 mg/1
source: ndc
Packaging
  • 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1883-1)
  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1883-2)
  • 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1883-3)
  • 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1883-4)
source: ndc

Packages (4)

71335-1883-1 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1883-1) 71335-1883-2 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1883-2) 71335-1883-3 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1883-3) 71335-1883-4 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1883-4)

Ingredients (1)

divalproex sodium (500 mg/1)

Linked Drug Pages (1)

Divalproex sodium ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "6dcd8d8d-3860-46c8-a8dd-3003604bc821", "openfda": {"unii": ["644VL95AO6"], "rxcui": ["1099569"], "spl_set_id": ["0822300b-68c0-4e70-b1ba-8eb42cf373f7"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1883-1)", "package_ndc": "71335-1883-1", "marketing_start_date": "20240718"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1883-2)", "package_ndc": "71335-1883-2", "marketing_start_date": "20210621"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1883-3)", "package_ndc": "71335-1883-3", "marketing_start_date": "20220818"}, {"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1883-4)", "package_ndc": "71335-1883-4", "marketing_start_date": "20220818"}], "brand_name": "Divalproex sodium", "product_id": "71335-1883_6dcd8d8d-3860-46c8-a8dd-3003604bc821", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "71335-1883", "generic_name": "Divalproex sodium", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Divalproex sodium", "active_ingredients": [{"name": "DIVALPROEX SODIUM", "strength": "500 mg/1"}], "application_number": "ANDA209286", "marketing_category": "ANDA", "marketing_start_date": "20200918", "listing_expiration_date": "20261231"}